What Is the Treatment of Oral Lichen Planus?
Oral lichen planus presents across a clinical spectrum — from localised white plaques to diffuse ulcerative and erosive involvement. Treatment selection is guided by lesion type, extent, and severity.
Clinical Scenario
This protocol addresses oral lichen planus as a primary diagnosis, covering the full range of presentations: localised OLP, ulcerative OLP, and diffuse or recalcitrant erosive OLP. The approach is structured around matching intervention intensity to disease severity.
Treatment Approach — Partial Overview
Corticosteroid-based therapy is the backbone of management, with the route of administration selected according to lesion extent and clinical presentation. When corticosteroids alone prove insufficient, further systemic options form part of the structured approach.
The complete agent selection, decision algorithm, and management of refractory disease are in the full structured protocol below.
References
DOI: 10.1111/jdv.16464
- Topical application of potent or ultrapotent steroids is the mainstay of treatment in the case of localized OLP.
- Clobetasol propionate 0.05%, triamcinolone, betamethasone, fluocinonide, fluticasone, dexamethasone and prednisolone in different forms have been proved to be effective and safe.
- Usually, twice-daily application of topical steroids for 1-2 months, and then administered as needed, is a common practice.
- Intralesional injection of corticosteroids (triamcinolone acetonide hydrocortisone, dexamethasone and methylprednisolone) in ulcerative OLP is also an effective treatment approach.
- Injections can be painful; to avoid mucosal atrophy, we usually administer a corticosteroid dilution of 10 mg/mL.
- Systemic corticosteroids, methylprednisolone or prednisone (30–80 mg/day) are the most effective treatment modality for patients with diffuse recalcitrant erosive OLP or multisite lesions of severe erosive OLP.
- Systemic retinoids, such as acitretin (25–50 mg/day) initially, followed by isotretinoin (0.5–1 mg/kg/day), have been used in the treatment of OLP.
- Topical retinoids (isotretinoin 0.05–0.1%) or other forms of vitamin A derivatives can eliminate white lesions, but in all cases reported the lesions relapsed 2–5 weeks after discontinuation of treatment.
- Systematic use of cyclosporine (3–10 mg/kg/day) has been found to be effective in different studies and for some authors is considered to be the drug of choice.